期刊文献+

依那西普治疗白塞病难治性色素膜炎一例并文献复习 被引量:3

原文传递
导出
摘要 患者男,37岁。因右眼视力下降5年,角膜移植术后19d,视力进一步下降1周入我院。患者右眼视力模糊伴反复口腔溃疡5年,左眼视力下降2年,伴皮肤针刺反应阳性,诊断白塞病、双眼色素膜炎。给予散瞳等一般眼科处理,局部或(和)全身糖皮质激素(以下简称激素)治疗,当泼尼松减量至20mg/d时,疾病复发。2年前除给予口服激素治疗外,并加用多种免疫抑制剂治疗(单用或联用环孢素A、环磷酰胺、硫唑嘌呤及雷公藤多苷等),但效果不理想,右眼视力进行性下降。
出处 《中华内科杂志》 CAS CSCD 北大核心 2007年第10期853-854,共2页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献8

  • 1Krause L. Adamantiades-Behcet' s disease. Ophthalmologe, 2005, 102 : 329-334.
  • 2Houman MH, Hamzaoui K. Promising new therapies for Behcet's disease. Eur J Intern Med,2006,17 : 163-169.
  • 3Falappone PC, Iannone F, Scioscia C, et al. The treatment of recurrent uveitis with TNF-alpha inhibitors. Reumatismo,2004,56 : 185-189.
  • 4Slobodin G, Toukan Y, Rosner I, et al. LPS-stimulated production of TNF-alpha by peripheral blood monocytes in patients with Behcet's disease. Clin Rheumatol,2007 ,26 :764-767.
  • 5Keller M, Spanou Z, Schaerli P, el al. T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol,2005 ,175 :7678-7686.
  • 6AhnJK, Yu HG, Chung H, et al. Intraocular cytokine environment in active Behcet uveitis. Am J Ophthalmol,2006,142 : 4-29-434.
  • 7Melikoglu M, Fresko I, Mat C, et al. Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study. J Rheumatol,2005 ,32 :98-105.
  • 8Saurenmann RK, Levin AV,Rose JB,et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology ( Oxford ) ,2006,45:982-989.

同被引文献225

  • 1张卓莉,彭劲民,侯小萌,董怡.1996例白塞病患者的临床荟萃分析[J].北京医学,2007,29(1):10-12. 被引量:67
  • 2刘相东,孙善会,肖东杰,牟国营,汪运山.白细胞介素-1受体拮抗剂基因型2/2与白塞病葡萄膜炎易感性的相关研究[J].山东大学学报(医学版),2007,45(5):467-469. 被引量:7
  • 3Krause I, Weinberger A. Behcet's disease. Curr Opin Rheumatol, 2008, 20:82-87.
  • 4Yates PA, Michelson JB. Behcet disease. Int Ophthalmol Clin, 2006, 46:209-233.
  • 5Bonfioli AA, Orefice F. Behcet's disease. Semin Ophthalmol, 2005, 20 : 199-206.
  • 6Kaklamani VG, Kaklamanis PG. Treatment of Behcet's disease-- an update. Semin Arthritis Rheum, 2001, 30:299-312.
  • 7Munoz-Fernandez S, Hidalgo V, Fernandez-Melon J, et al. Effect of infliximab on threatening panuveitis in Beheet' s disease. Lancet, 2001,358 : 1644.
  • 8Sfikakis PP, Theodossiadis PG, Katsiari CG, et al. Effect of infliximab on sight-threatening panuveitis in Behcet's disease. Lancet, 2001, 358: 295-296.
  • 9Sfikakis PP, Markomichelakis N, Alpsoy E, et al. Anti-TNF therapy in the management of Behcet's disease-review and basis for recommendations. Rheumatology, 2007, 46 : 736-741.
  • 10Criteria for diagnosis of Behcet's disease. International study group for Behcet's disease. Lancet, 1990, 335 : 1078-1080.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部